北京市公立医院药品采购价将网上公示

2015-07-06 佚名 北京青年报

北京市所有公立医疗机构药品未来将全部实行网上采购,采购品种、采购价格、采购数量、药品调整变化情况等都将公开,同时,以全国省级药品集中采购最低价为重要参考,实行多方谈判,实现成果共享。此外,平台将药品分为4个目录,实行分类采购。针对市场供应充足、竞争激烈的产品,以全国最低价作为重要参考指标,而市场短缺特别是低价临床必需品,医疗机构可通过价格杠杆,让市民“用得起、用得上”。日前,市卫生计生委印发了《关

北京市所有公立医疗机构药品未来将全部实行网上采购,采购品种、采购价格、采购数量、药品调整变化情况等都将公开,同时,以全国省级药品集中采购最低价为重要参考,实行多方谈判,实现成果共享。此外,平台将药品分为4个目录,实行分类采购。针对市场供应充足、竞争激烈的产品,以全国最低价作为重要参考指标,而市场短缺特别是低价临床必需品,医疗机构可通过价格杠杆,让市民“用得起、用得上”。

日前,市卫生计生委印发了《关于我市公立医疗机构医药产品阳光采购工作实施方案》,并正式启动药品阳光采购工作。根据方案,未来本市所有公立医疗机构药品将全部在该平台实行网上采购,采购品种、采购价格、采购数量、药品调整变化情况等都将公开,保证阳光运行。

按照方案,“阳光采购”将坚持全市一个采购平台,所有公立医疗机构的在用药品全部在政府搭建的平台上实行网上采购。同时,以全国省级药品集中采购最低价为重要参考价格,实行多方谈判、动态联动,实现成果共享。

通过搭建“阳光平台”,政府职能将逐步实现由重运行到强监管的转变,平台也逐步实现由操作平台到服务平台的转变。据了解,阳光采购还将通过“四公开”,即公开公立医疗机构采购品种、采购价格、采购数量、药品调整变化情况,晒出采购清单,确保药品采购各环节在阳光下运行。

为方便群众就医,也为双向转诊提供有力的药品供应保障,方案在医保、医疗、医药等综合配套措施框架下,鼓励医联体、医院集团等联合采购,逐步统一核心医院与基层机构的药品目录,定期汇总全市医疗机构药品实际购用清单并向社会公布,通过带量采购等措施,实现量价挂钩。

根据临床用量和市场供应情况,平台将药品分为4个目录,实行分类采购。针对市场供应充足、竞争激烈的产品,以全国最低价作为重要参考指标。针对市场短缺特别是价格低廉的临床必需品,医疗机构可通过价格杠杆有效缓解供应紧张的问题,努力让市民“用得起、用得上”。

市卫计委相关负责人表示,阳光采购将坚持以市为单位的集中采购方向和质量、需求、价格相统一的采购原则,在推进医保基金总额预付等改革措施框架下,充分发挥市场在资源配置中的决定性作用和更好发挥政府作用,进一步保障临床诊疗需求,预防和遏制药品购销领域腐败行为,降低虚高价格,构建公开透明的药品购销体系,推动破除以药补医等综合改革。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
    2015-07-08 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
    2015-07-08 wolongzxh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
    2015-07-06 保守主义

    趋势

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1814434, encodeId=e7331814434d4, content=<a href='/topic/show?id=f2e59566619' target=_blank style='color:#2F92EE;'>#采购价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95666, encryptionId=f2e59566619, topicName=采购价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Thu May 05 15:04:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31613, encodeId=9470316135a, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532684, encodeId=8511153268474, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537775, encodeId=67d9153e775c7, content=<a href='/topic/show?id=86f38e504fe' target=_blank style='color:#2F92EE;'>#药品采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87504, encryptionId=86f38e504fe, topicName=药品采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d5f12898837, createdName=zhaozuguo, createdTime=Wed Jul 08 09:04:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30933, encodeId=3dd430933df, content=趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30934, encodeId=43043093425, content=趋势啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Mon Jul 06 20:33:00 CST 2015, time=2015-07-06, status=1, ipAttribution=)]
    2015-07-06 保守主义

    趋势啊

    0

相关资讯

推进药品价格改革答记者问

近日,经国务院同意,国家发展改革委会同国家卫生计生委、人力资源社会保障部等部门发出通知,决定自2015年6月1日起取消绝大部分药品政府定价,同步完善药品采购机制,强化医保控费作用,强化医疗行为和价格行为监管,建立以市场为主导的药品价格形成机制。就有关问题,记者采访了国家发展改革委有关负责人。  问:为什么选择这个时机进行药品价格改革?  答:2000年以来,根据国务院的要求,价格主管部门对

Nature:为药品价格分层制度敲警钟

日前,全球医疗卫生领域热心人士及研究者们正在反对一项提案,提案将允许制药公司提高在许多发展中国家的必需药品的售价。 5月13日,由220个非政府组织(NGO)组成的联合会共同谴责一项提案,该提案由全球对抗艾滋病、结核病及疟疾基金会(Global Fund to Fight AIDS, Tuberculosis and Malaria)发布,旨在推动药品的分层定价(tiered